Literature DB >> 9571666

Recalcitrant malignant glaucoma following pars plana vitrectomy, scleral buckle, and extracapsular cataract extraction with posterior chamber intraocular lens implantation.

P T Zacharia1, E B Abboud.   

Abstract

Pars plana vitrectomy is employed to treat cases of aqueous misdirection that are refractory to medical and laser treatment. The authors describe a 65-year-old man without previous aqueous misdirection in whom this condition developed after a procedure that included pars plana vitrectomy. The aqueous misdirection recurred despite multiple interventions, including medical treatment, transiently successful Nd:YAG laser capsulo-hyaloidotomy, and surgical disruption of the anterior hyaloid face. It finally resolved after repeated pars plana vitrectomy with hyaloido-capsulo-iridectomy. There has been no recurrence 7 months after this procedure. The authors conclude that the surgical treatment of aqueous misdirection refractory to more conservative measures should include adequate disruption of the anterior hyaloid to prevent recurrence.

Entities:  

Mesh:

Year:  1998        PMID: 9571666

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  5 in total

1.  An unusual presentation of aqueous misdirection.

Authors:  A Koukkoulli; R Rahman
Journal:  Eye (Lond)       Date:  2013-03-01       Impact factor: 3.775

2.  Aqueous misdirection following pars plana vitrectomy and silicone oil injection.

Authors:  Hammouda H Ghoraba; Ali Ahmed Ghali; Hosam Othman Mansour
Journal:  Clin Ophthalmol       Date:  2015-05-20

3.  Long-term follow-up of zonulo-hyaloido-vitrectomy for pseudophakic malignant glaucoma.

Authors:  Indira M Madgula; Nitin Anand
Journal:  Indian J Ophthalmol       Date:  2014-12       Impact factor: 1.848

4.  Repositioning of glaucoma tubes into the pars plana for refractory malignant glaucoma: a case report.

Authors:  Julia Song; Alessandro Castellarin; Michael Song; Alice Song
Journal:  J Med Case Rep       Date:  2013-04-11

Review 5.  Acute and chronic fluid misdirection syndrome: pathophysiology and treatment.

Authors:  Andrzej Grzybowski; Piotr Kanclerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-06       Impact factor: 3.535

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.